thiorphan has been researched along with Osteosarcoma in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizerska-Kowalska, M | 1 |
| Sławińska-Brych, A | 1 |
| Niedziela, E | 1 |
| Brodovskiy, V | 1 |
| Zdzisińska, B | 1 |
1 other study available for thiorphan and Osteosarcoma
| Article | Year |
|---|---|
Alpha Ketoglutarate Downregulates the Neutral Endopeptidase and Enhances the Growth Inhibitory Activity of Thiorphan in Highly Aggressive Osteosarcoma Cells.
Topics: Bromodeoxyuridine; Epigenesis, Genetic; Histones; Humans; Ketoglutaric Acids; Neprilysin; Osteosarco | 2022 |